Carlos A. de Solo is the CEO of CareMax, Inc., a company focused on Medicare value-based care. With a Bachelor’s degree in Business Administration from the University of Florida, he has a solid background in business management. Under Carlos’s leadership,...

Carlos A. de Solo is the CEO of CareMax, Inc., a company focused on Medicare value-based care. With a Bachelor’s degree in Business Administration from the University of Florida, he has a solid background in business management. Under Carlos’s leadership, CareMax has worked on various strategic initiatives, including a significant acquisition that enhanced its capabilities in the healthcare market. He started as CEO in June 2021, bringing a fresh perspective at a crucial time, especially with changing trends in healthcare. In 2022, Carlos received a total compensation of $970,000, reflecting his performance-driven approach. His bonus that year was tied to the company's growth, demonstrating that he prioritizes results. He also saw 10,000 shares of stock vest in 2022 as part of a long-term incentive plan, showing his commitment to the company's future success. Carlos’s family, with his brother Alberto also an executive at CareMax, adds a unique dynamic to the leadership team, which is built on strong familial ties and mutual goals.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other CareMax, Inc. CEOs

C

Carlos A. de Solo

Founder and Ex-CEO of CareMax, Inc.

Education

Bachelor's degree in Business Administration from the University of Florida

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

September 15, 1968 - 56 years ago

CEO of CareMax, Inc. for

1 year 5 months (Jun 2021 - Nov 2022)

Previous Experience

Co-founder and CEO of CareMax, Inc.

Rivals

Competitors/colleagues of Carlos A. de Solo

Holdings

See how much did Carlos A. de Solo make over time.

As the current CEO of CareMax, Carlos A. de Solo has significant holdings in the company, particularly through vested stocks. In 2022, he had 10,000 shares in restricted stock units (RSUs) that were part of a long-term incentive plan, which...

As the current CEO of CareMax, Carlos A. de Solo has significant holdings in the company, particularly through vested stocks. In 2022, he had 10,000 shares in restricted stock units (RSUs) that were part of a long-term incentive plan, which were valued at around $300,000 at the time of vesting. The value of his stock has fluctuated as the market conditions changed, reflecting both the company's performance and overall market trends. Previously, in 2021, Carlos's holdings included 5,000 RSUs valued at about $150,000. He has seen a significant increase in his stock worth over the years, emphasizing his personal stake in CareMax's success. The growth of his holdings clearly ties back to his role in steering the company towards increased profitability and efficiency, as evidenced by his active engagement in influencing revenue metrics and operational improvements.

No data yet.

Insider Trading

See recent insider trades of Carlos A. de Solo.

No insider trades found for this CEO.

Compensation History

See how much did Carlos A. de Solo make over time.

Carlos A. de Solo's compensation package is structured to align with company performance, emphasizing his contribution to CareMax's growth. In 2022, he received a total of $970,000, which included a base salary of $500,000, a performance-based bonus of $150,000, and a vested stock value of $300,000 from previously granted restricted stock units (RSUs). This structure reflects a focus on long-term value creation, rewarding Carlos for reaching key performance metrics like revenue growth and operational efficiency. In contrast, in 2021, his total compensation was $700,000, showcasing a direct connection between the company's success and executive rewards. Carlos's package also includes other benefits like health coverage and retirement contributions, further incentivizing him to drive CareMax forward.

Year

2022

Total Compensation

$970.00K

Salary

$500.00K

Board Justification

The compensation philosophy aligns with company performance, focusing on long-term value creation and retention of key executives through competitive pay and performance-based incentives.

Bonus

$150.00K

Board Justification

The bonus is based on the achievement of specific performance metrics related to company growth and profitability for the year 2022.

Other

$20.00K

Board Justification

Other compensation includes health benefits and retirement contributions paid in 2022.

Restricted Stock

$300.00K(10K RSU)

Board Justification

The stock that vested in 2022 was part of a long-term incentive plan, which is based on performance over a three-year period, with 10,000 shares vesting this year.

Performance Metrics

Performance metrics included revenue growth, EBITDA targets, and operational efficiency improvements.

Other CareMax, Inc. CEOs

Here are other CEOs of CareMax, Inc.

Dr. Ralph de la Torre

Ex-CEO of CareMax, Inc.

November 2022 - October 2023